41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
2135703
178559
2
Public Timelines
FAQ

oct 31, 2016 - FDA held a public meeting, Pre-Market Evaluation of Abuse-Deterrent Properties of Opioid Drug Products, to discuss scientific and technical issues relating to formulation development and pre- market evaluation of opioid drug products with abuse-deterrent properties.

Added to timeline:

13 Nov 2018
0
0
549

Date:

oct 31, 2016
Now
~ 9 years and 7 months ago